Key facts
- It has raised $313.0M across 3 recorded rounds; the latest was Later Stage VC ($81.0M) in Nov 2024.
- Notable investors include RA Capital Management, Deerfield Management, Optum Ventures, CVS Health Ventures, Echo Health Ventures — 16 tracked in total.
- Cortica has filed 4 Form Ds with the SEC since 2023, most recently Nov 2024 ($81.0M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Cortica
Funding rounds
3 roundsAbout Cortica
Operator of a healthcare company intended to provide ABA, speech, occupational therapy, and medical services to children with autism and other neurodevelopmental disorders. The company's services include evidence-based treatments to restore opportunities for independent living, higher education, career development, and social relationships, providing children with developmental differences to achieve long-lasting, transformative results.
- Industry
- Clinics/Outpatient Services
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2014
- Employees
- 2,000
- Website
- corticacare.com/
- Ownership
- Privately Held (backing)
Cortica doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cortica shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cortica in its N-PORT filings yet. We sweep new filings monthly.